Karima Salway is an associate in the London office of Latham & Watkins, and is a member of the Corporate Department.
Ms. Salway's practice focuses on UK and cross-border mergers and acquisitions, reorganizations and general corporate matters.
Prior to joining Latham, Ms. Salway was an associate in the corporate department at DLA Piper, during which time she spent six months on secondment to the corporate and M&A legal team at Lloyds Banking Group where she advised on a range of corporate and commercial matters.
Ms. Salway's experience includes advising:
- Sienna Biopharmaceuticals in connection with its acquisition of Creabilis plc, a privately held specialty pharmaceutical company
- Carbylan Therapeutics, Inc., a developer of clinical-stage specialty pharmaceutical treatments, in connection with the reverse merger of Carbylan Therapeutics with KalVista Pharmaceuticals
- The Michelin Group on the acquisition of BookaTable, the online restaurant booking provider*
- The founders of Lansdowne Chemicals plc in the sale of the chemical manufacturing and distribution company to Overlack AG*
*Matters completed whilst at another firm